As a candidate oncogene, RPLP2 is overexpressed and closely associated with occurrence and progression of various cancers including but not limited to breast, ovarian, colon, lung cancer and AML [18–21], while there is no reports about the effect of RPLP2 on HCC. This evidence concerns the gene RPLP2 and hepatocellular carcinoma.